November 3, 2015 / 12:57 PM / 2 years ago

BRIEF-GSK CEO sees Nucala, Shingrix, anaemia pill, antivirals as pipeline highlights

Nov 3 (Reuters) - Glaxosmithkline Plc CEO on media call:

* Calls out Nucala for severe asthma, Shingrix for shingles as exciting products, along with daprodustat in anaemia and drugs for viral diseases

* says respiratory medicine will probably not be as important part of company in future

* says no target figure for research and development spending, has moved investment from fixed assets to projects

* says very confident company has resources to fund current pipeline Further company coverage: (Reporting by UK bureau)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below